ADC Therapeutics SA Financial Ratios
ADCT|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-
Profit Margin
-175.3%
Net Income / Revenue
Asset Turnover
0.25
Revenue / Total Assets
Equity Multiplier
-1.74
Total Assets / Equity
Profitability
Liquidity
Current Ratio
4.37
Quick Ratio
4.31
Solvency
Interest Coverage
-8.67
Efficiency
Asset Turnover
0.25
Inventory Turnover
1.39
Days Sales Outstanding
-
As of FY2025 · SEC 10-K · Updated Jun 24, 2026
Earnings Quality
Accrual Ratio
-0.4%
+37.2pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.